The Food and Drug Administration in recent months has approved a small number of drugs quite quickly under a new expedited review program. But Health and Human Services Secretary Robert F. Kennedy Jr. has overstated the impact of the program by making misleading comparisons to the pace of drug approvals in the past.
In a hyped press briefing the eve before the Republican National Convention, President Donald Trump falsely said that convalescent plasma had been “proven to reduce mortality by 35%,” even though the therapy has not yet been shown to be effective for COVID-19.
Amid criticism over his administration’s response to the coronavirus outbreak, President Donald Trump falsely claimed that he had to overcome an Obama-era Food and Drug Administration “rule” to more quickly provide diagnostic tests to the American people. Experts, however, told us no such formal regulation was ever implemented under the previous administration.